The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Survival after radiation therapy for early-stage endometrial carcinoma: The Oslo study revisited after up to 43 years of follow-up.
Kristina Lindemann
No relevant relationships to disclose
Mathias Onsrud
No relevant relationships to disclose
Gunnar Kristensen
Consultant or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche
Claes Trope
No relevant relationships to disclose